To confirm the effect of the new selenoester on cell arrest in different phases of the cell cycle, cyclin E1 and cyclin A2 activity was analyzed by flow cytometry in MCF-7 and MDA-MB-231 breast cancer cells (24 h; EDA-71 and cisplatin at 1.5 and 3 μM). Here, CCNA2 is linked to breast cancer.